- Home
- CATO vs CNTB Comparison
CATO vs CNTB Comparison
Compare CATO & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- CNTB
- Stock Information
- Founded
- CATO 1946
- CNTB 2012
- Country
- CATO United States
- CNTB United States
- Employees
- CATO N/A
- CNTB N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- CATO Consumer Discretionary
- CNTB Health Care
- Exchange
- CATO Nasdaq
- CNTB Nasdaq
- Market Cap
- CATO 88.2M
- CNTB 93.9M
- IPO Year
- CATO N/A
- CNTB 2021
- Fundamental
- Price
- CATO $3.44
- CNTB $2.74
- Analyst Decision
- CATO
- CNTB Strong Buy
- Analyst Count
- CATO 0
- CNTB 3
- Target Price
- CATO N/A
- CNTB $8.33
- AVG Volume (30 Days)
- CATO 71.6K
- CNTB 396.4K
- Earning Date
- CATO 11-20-2025
- CNTB 11-12-2025
- Dividend Yield
- CATO N/A
- CNTB N/A
- EPS Growth
- CATO N/A
- CNTB N/A
- EPS
- CATO N/A
- CNTB N/A
- Revenue
- CATO $650,830,000.00
- CNTB $762,000.00
- Revenue This Year
- CATO N/A
- CNTB N/A
- Revenue Next Year
- CATO N/A
- CNTB $453,067.90
- P/E Ratio
- CATO N/A
- CNTB N/A
- Revenue Growth
- CATO N/A
- CNTB N/A
- 52 Week Low
- CATO $2.19
- CNTB $0.51
- 52 Week High
- CATO $6.30
- CNTB $3.18
- Technical
- Relative Strength Index (RSI)
- CATO 37.77
- CNTB 80.86
- Support Level
- CATO $3.41
- CNTB $1.49
- Resistance Level
- CATO $3.80
- CNTB $1.74
- Average True Range (ATR)
- CATO 0.17
- CNTB 0.22
- MACD
- CATO -0.03
- CNTB 0.13
- Stochastic Oscillator
- CATO 18.18
- CNTB 99.25
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.